Role of Visfatin in Chronic Kidney Disease: Diagnostic Potential and Association with Hemodialysis
These findings indicate that serum visfatin and NAMPT gene expression could serve as novel biomarkers for assessing CKD severity, particularly in patients undergoing hemodialysis, with potential implications for managing inflammation and cardiovascular risk in CKD.
Authors
- Mohamadreza Tavakoli (ORCID: https://orcid.org/0000-0002-5739-1909)
- Marjan Mirhaj (ORCID: https://orcid.org/0000-0002-5310-1409)
- Mastafa H. Al‐Musawi (ORCID: https://orcid.org/0000-0001-8698-815X)
- Hawazin Aziz Hamim
- Mina Shahriari-Khalaji
- Nisreen Ahmed Hamzah
- Dunia Abdul Jabbar Satar
Institutions
- Mustansiriyah University (IQ)
- Isfahan University of Technology (IR)
- Middle Technical University (IQ)
- Iraq University College (IQ)
- Rowan University (US)
Publication Details
- Journal
- Reports of Biochemistry and Molecular Biology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.61882/rbmb.14.1.57
- Primary Topic
- Adipokines, Inflammation, and Metabolic Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00